p53 Codon 72 polymorphism and urothelial cancer risk

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• The p53 tumor suppressor gene plays a crucial role in preventing cancer.
• Mutations in the p53 gene are common in human cancers.
• The p53 codon 72 polymorphism is investigated as a potential cancer risk factor.

Purpose of the Study:

• To examine the genotype distribution of the p53 codon 72 polymorphism in male urothelial cancer patients and controls.
• To determine if the p53 codon 72 polymorphism is associated with urothelial cancer risk.
• To investigate the interaction between p53 codon 72 polymorphism and smoking status in urothelial cancer.

Main Methods:

• Case-control study design.
• Genotyping of p53 codon 72 polymorphism in 112 male urothelial cancer cases and 175 male controls.
• Analysis of genotype frequencies and allelic frequencies.
• Stratification by smoking status (including pack-years) to assess gene-environment interactions.

Main Results:

• No significant difference in p53 codon 72 genotype frequencies between overall urothelial cancer cases and controls.
• A significantly higher frequency of the Pro/Pro genotype was observed in smokers compared to never-smokers (OR=2.28).
• The Pro/Pro genotype showed a markedly increased odds ratio for urothelial cancer in lighter smokers (<20 pack-years) (OR=6.83).

Conclusions:

• The p53 codon 72 Pro/Pro genotype may increase the risk of urothelial cancer, particularly in male smokers.
• Smoking acts as a significant modifier of the risk associated with the p53 Pro/Pro genotype.
• Further research is warranted to elucidate the mechanisms underlying this gene-environment interaction in urothelial carcinogenesis.